Educational material about research reagents; not medical advice, rehabilitation coaching, or human-use instructions.
The query "peptides for recovery", "BPC-157", "TB-500", or "joint peptides" is useful for navigation but scientifically loose: it mixes repair peptides (BPC/TB), anti-fibrosis agents (AC-SDKP), neuroregeneration (ARA-290), cosmetic GHK/SNAP-8 narratives, GLP-1 (weight loss), IGF/myostatin (muscle), and lab RUO vials. Longeva hub does not sell a "recovery program". This page is a shelf map: who owns the healing-regeneration commercial aisle, where hub wiki and editorial pillars live, and where the research use only (RUO) boundary sits.
Regena as canonical owner of the repair aisle
| Layer | Where | What you get |
|---|---|---|
| Healing / recovery RUO catalog | Regena · healing-regeneration | BPC-157, TB-500, KLOW, GHK-Cu, KPV, LL-37, BMP-7, HGF, AC-SDKP + COA |
| Joint goal-shelf | Regena · BPC/TB joints | Deep RUO guide: tissue, model, readout |
| BPC + TB hub editorial | BPC-157 and TB-500, blend pillar | Two-molecule context and blend vs mono |
| GLP-1 / weight loss | hub · weight loss, Incretin | Semaglutide ≠ BPC-157 |
| Muscle / IGF | hub · muscle | Hypertrophy shelf, not repair |
| Longevity | hub · longevity, Evity | Anti-age cluster, not healing-regeneration |
Regena is the canonical owner of healing-regeneration SKUs. Hub stays editorial + navigation without a buy CTA on Regena SKUs.
Repair sub-aisles: not everything is "for joints"
- Tissue repair / tendon-ligament. BPC-157, TB-500, blend, KLOW.
- Anti-fibrosis. AC-SDKP, BMP-7, HGF.
- Neuroregeneration. ARA-290.
- Skin / matrix research. GHK-Cu, SNAP-8, different search intent.
BPC-157, TB-500, GHK-Cu: where to read about each
| Cluster | Molecule | Hub wiki | Hub editorial | RUO on Regena |
|---|---|---|---|---|
| Tissue repair | BPC-157 | wiki | review | card |
| Tissue repair | TB-500 | wiki | review | card |
| Blend | BPC-157 + TB-500 | KLOW | blend pillar | card |
| Matrix | GHK-Cu | wiki | review | card |
RUO framing
- A RUO vial carries INN and fill weight; COA describes batch analytics, not a clinical "healed joint" outcome.
- Data from one tissue or model do not transfer to another without a new protocol.
- "Post-workout recovery" in marketing describes the search topic, not a verified vial effect.
Three aisles confused with recovery
| Topic | Destination | Why not recovery |
|---|---|---|
| Weight loss, GLP-1 | hub · weight loss | Incretin metabolic axis |
| IGF, myostatin | hub · muscle | Hypertrophy shelf |
| Anti-age | hub · longevity | Evity shelf |
Brand chooser: buy peptides · pick a brand.
Blends in one vial: why a single purity figure says nothing
Repair is the only aisle in the catalog where single-molecule SKUs sit next to a blend, meaning two active substances in one vial. For that format the familiar single-purity-line report structurally does not work.
- A blend needs two quantities and a ratio. BPC-157 plus TB-500 in one vial is two peaks on the chromatogram. "98% purity" is undefined for a mixture: 98% of what, and in what proportion? A correct report gives the content of each component separately, which also makes the actual ratio visible.
- Same name, different molecules. "TB-500" on the market covers both full-length thymosin beta-4 at 43 amino acids and the short active fragment. These are different substances with different masses, so the identity section rather than the label name is what tells you which is in the vial.
- One certificate covering mono and blend is a mistake. A blend is a separate product with its own LOT. If a seller offers a mono-BPC COA as evidence for the mixture, the mixture batch has no evidence at all.
- Acetate and TFA as synthesis residues. For solid-phase peptides, residual trifluoroacetate affects cell experiments. It belongs on its own line in the report, and its absence is a real gap rather than a formality.
- LOT match against the PDF in the COA archive; verify a lot at
/verify/{lot}.
Rule for the repair aisle: for a mixture, ask for two numbers rather than one. A single purity figure on a blend is either a report for a different product or a metric that constrains nothing.
Three mistakes in joint-recovery queries
- "Best peptide for joints". Hub does not rank.
- Mix BPC/TB with GLP-1 or IGF. Different aisles.
- Read animal-model histology as a vial promise.
Repair molecule reference
Where to read next
Longeva hub · navigational only · does not replace a lab protocol.